Barclays Starts Gilead Sciences (GILD) at Overweight, Sets $67 Price Target
Tweet
Share
E-mailGet Alerts GILD Hot Sheet
Price: $143.72 -0.75%
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Rating Summary:
36 Buy, 7 Hold, 1 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 3 | Down: 5 | New: 34
Join SI Premium – FREE
Barclays initiates coverage on shares of Gilead Sciences (NASDAQ: GILD) with an Overweight rating and $67 price target.
For an analyst ratings summary and ratings history on Gilead Sciences click here. For more ratings news on Gilead Sciences click here.
Shares of Gilead Sciences closed at $53.73 yesterday.
For an analyst ratings summary and ratings history on Gilead Sciences click here. For more ratings news on Gilead Sciences click here.
Shares of Gilead Sciences closed at $53.73 yesterday.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Gilead Sciences (GILD) PT Raised to $175 at HSBC
- Needham Starts Next Vision Stabilized Systems (NXSN:IT) at Buy
- CLSA Starts Shenzhen Senior Technology Material Co (300568:CH) at Outperform (2)
Create E-mail Alert Related Categories
New CoverageRelated Entities
BarclaysSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
